Related Experiment Video
Updated: Aug 25, 2025

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
TPM1 mediates inflammation downstream of TREM2 via the PKA/CREB signaling pathway
Rong Li1,2, Jing Zhang3, Qiong Wang4
1School of Optometry, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong. rong-rong.li@connect.polyu.hk.
Background:
Microglia, the innate immune cells in the central nervous system, play an essential role in brain homeostasis, neuroinflammation and brain infections. Dysregulated microglia, on the other hand, are associated with neurodegenerative diseases, yet the mechanisms underlying pro-inflammatory gene expression in microglia are incompletely understood.
Methods:
We investigated the role of the actin-associated protein tropomyosin 1 (TPM1) in regulating pro-inflammatory phenotype of microglia in the retina by using a combination of cell culture, immunocytochemistry, Western blot, qPCR, TUNEL, RNA sequencing and electroretinogram analysis. TREM2-/- mice were used to investigate whether TPM1 regulated pro-inflammatory responses downstream of TREM2. To conditionally deplete microglia, we backcrossed CX3CR1CreER mice with Rosa26iDTR mice to generate CX3CR1CreER:Rosa26iDTR mice.
Results:
We revealed a vital role for TPM1 in regulating pro-inflammatory phenotype of microglia. We found that TPM1 drove LPS-induced inflammation and neuronal death in the retina via the PKA/CREB pathway. TPM1 knockdown ameliorated LPS-induced inflammation in WT retinas yet exaggerated the inflammation in TREM2-/- retinas. RNA sequencing revealed that genes associated with M1 microglia and A1 astrocytes were significantly downregulated in LPS-treated WT retinas but upregulated in LPS-treated TREM2-/- retinas after TPM1 knockdown. Mechanistically, we demonstrated that CREB activated by TPM1 knockdown mediated anti-inflammatory genes in LPS-treated WT retinas but pro-inflammatory genes in LPS-treated TREM2-/- retinas, suggesting a novel role for TREM2 as a brake on TPM1-mediated inflammation. Furthermore, we identified that TPM1 regulated inflammation downstream of TREM2 and in a microglia-dependent manner.
Conclusions:
We demonstrate that TPM1 mediates inflammation downstream of TREM2 via the PKA/CREB signaling pathway. Our findings suggest that TPM1 could be a potential target for therapeutic intervention in brain diseases.
Insights
Tropomyosin 1 (TPM1) regulates microglial inflammation via the PKA/CREB pathway, acting downstream of TREM2. Targeting TPM1 offers a potential therapeutic strategy for neurodegenerative diseases.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia are key innate immune cells in the central nervous system, crucial for brain health.
- Dysfunctional microglia are implicated in neurodegenerative diseases, but mechanisms of pro-inflammatory gene expression remain unclear.
Purpose of the Study:
- To investigate the role of tropomyosin 1 (TPM1) in regulating microglial pro-inflammatory responses.
- To elucidate the signaling pathways and receptor interactions involved in TPM1-mediated microglial activation.
Main Methods:
- Utilized cell culture, immunocytochemistry, Western blot, qPCR, TUNEL, RNA sequencing, and electroretinogram analysis.
- Employed TREM2 knockout and CX3CR1-CreER/Rosa26-iDTR mice for conditional microglial depletion and TREM2 function studies.
Main Results:
- TPM1 drives lipopolysaccharide (LPS)-induced retinal inflammation and neuronal death via the PKA/CREB pathway.
- TPM1 knockdown reduced inflammation in wild-type retinas but exacerbated it in TREM2 knockout retinas.
- TPM1 regulates inflammation downstream of TREM2 in a microglia-dependent manner, with CREB mediating differential gene expression.
Conclusions:
- TPM1 mediates neuroinflammation downstream of TREM2 through the PKA/CREB signaling pathway.
- TPM1 represents a potential therapeutic target for managing inflammatory brain diseases.
More Related Videos
09:51Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
07:55A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces
Published on: January 7, 2020
Related Concept Videos
TGF - β Signaling Pathway
MAPK Signaling Cascades
cAMP-dependent Protein Kinase Pathways
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...